PRODIGY BIOTECH Trademark

Trademark Overview


On Wednesday, April 26, 2023, a trademark application was filed for PRODIGY BIOTECH with the United States Patent and Trademark Office. The USPTO has given the PRODIGY BIOTECH trademark a serial number of 97908992. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Wednesday, July 24, 2024. This trademark is owned by Prodigy Biotech, Inc.. The PRODIGY BIOTECH trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations in the nature of IgY antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product for therapeutic and prophylactic use for humans and animals and for use in aquaculture; pharmaceutical preparations in the nature of IgY antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product for use in antibacterial treatments, anti-toxin treatments, anti-fungal treatments, anti-yeast treatments, anti-parasite treatments, anti-cytokine treatments, anti-receptor treatments, antibiotic treatments and antiviral treatments, for humans and animals and for use in aquaculture; pharmaceutical preparations in the nature of IgY antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product for repairing, modifying and modulating the intestinal microbiome; all of the foregoing excluding vaccines.
prodigy biotech

General Information


Serial Number97908992
Word MarkPRODIGY BIOTECH
Filing DateWednesday, April 26, 2023
Status653 - SUSPENSION LETTER - MAILED
Status DateWednesday, July 24, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations in the nature of IgY antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product for therapeutic and prophylactic use for humans and animals and for use in aquaculture; pharmaceutical preparations in the nature of IgY antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product for use in antibacterial treatments, anti-toxin treatments, anti-fungal treatments, anti-yeast treatments, anti-parasite treatments, anti-cytokine treatments, anti-receptor treatments, antibiotic treatments and antiviral treatments, for humans and animals and for use in aquaculture; pharmaceutical preparations in the nature of IgY antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product for repairing, modifying and modulating the intestinal microbiome; all of the foregoing excluding vaccines.
NOT AVAILABLE"BIOTECH"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 24, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameProdigy Biotech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWest Chester, PA 19382

Trademark Events


Event DateEvent Description
Monday, May 1, 2023NEW APPLICATION ENTERED
Wednesday, May 24, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 23, 2024ASSIGNED TO EXAMINER
Tuesday, April 23, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, April 23, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, July 23, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 23, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 23, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 24, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, July 24, 2024SUSPENSION LETTER WRITTEN
Wednesday, July 24, 2024LETTER OF SUSPENSION E-MAILED
Tuesday, January 23, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 23, 2024NON-FINAL ACTION WRITTEN
Tuesday, January 23, 2024NON-FINAL ACTION E-MAILED